Healthcare Insights

Anti-acne Cosmetics Market Size to Hit USD 11.64 Bn By 2033

The global anti-acne cosmetics market was estimated at USD 4.86 billion in 2023 and it is expected to surpass around USD 11.64 billion by 2033, poised to grow at a CAGR of 9.13% from 2024 to 2033.

Anti-acne Cosmetics Market Overview

The anti-acne cosmetics market has become a dynamic force within the beauty and skincare industry, driven by increasing consumer consciousness regarding skincare issues and a burgeoning desire for reliable solutions. This overview delves into the pivotal elements propelling the expansion of the anti-acne cosmetics market, encompassing market trends, product advancements, consumer inclinations, and industry hurdles.

Anti-acne Cosmetics Market Growth Factors

The growth of the anti-acne cosmetics market is fueled by several key factors. Firstly, increasing awareness about skincare and the desire for clear, blemish-free skin drive demand for effective acne management solutions. Consumers are actively seeking products that not only treat existing acne but also prevent future breakouts, leading to a surge in the adoption of anti-acne cosmetics. Additionally, advancements in formulation technologies and ingredient science have resulted in the development of innovative products with enhanced efficacy and safety profiles. The growing preference for natural and organic skincare solutions further propels market growth, as consumers seek gentle yet effective alternatives to traditional acne treatments. Moreover, the rise of social media influencers and online beauty communities amplifies product visibility and consumer education, driving further market expansion. Overall, these factors converge to create a conducive environment for the continued growth and evolution of the anti-acne cosmetics market.

Get Sample Copy@  https://www.visionresearchreports.com/report/sample/39047

Product Type Insights

In 2023, the creams and lotions segment dominated the market with a 42% share of the overall revenue and is projected to experience the fastest Compound Annual Growth Rate (CAGR) of 9.73% over the forecast period. This growth is attributed to high demand from both men and women, as moisturizing creams and body lotions play a crucial role in protecting the skin from bacteria and skin infections like psoriasis and eczema. Often, these creams and lotions are medicated and may contain Active Pharmaceutical Ingredients (API), vitamins such as vitamin A, and medications like antibiotics for acne caused by bacterial infections.

The global market is segmented into masks, creams and lotions, cleansers and toners, and others based on product type. The “others” category includes products such as face wash, gels, serums, and essential oils. These products aid in unclogging pores and reducing inflammation, as acne is characterized by both clogging and inflammation. They are available in various types based on ingredients and their intended use. For example, in March 2023, Galderma launched TWYNEO cream in the U.S. This cream contains a 2-in-1 combination of 3% benzoyl peroxide (BPO) and 0.1% tretinoin, designed to treat all types of acne.

Gender Insights

In 2023, the women’s anti-acne cosmetics segment held a dominant position in the global market, accounting for 53% of the revenue share and is anticipated to exhibit the fastest Compound Annual Growth Rate (CAGR) of 9.32% over the forecast period. The global market is categorized based on gender into women and men segments. The growth of the women’s segment can be attributed to the higher prevalence of acne among females globally. Acne tends to be more prevalent in women than in men after adolescence due to hormonal changes, such as those associated with the menstrual cycle.

According to a survey conducted by the Annals of International Medical and Dental Research, approximately 9.4% of the global population is estimated to experience acne, with adolescents being the most affected group. The burden of acne vulgaris-related conditions is widespread globally and has demonstrated an increasing prevalence among adolescents. Moreover, a growing body of epidemiological evidence suggests that acne also affects a significant number of adults, with adult women more commonly impacted by acne than men.

End-use Insights

In 2023, the medspa segment commanded the highest market share, accounting for approximately 64% of the market. This segment is also expected to exhibit the highest growth over the forecast period. The dominance of medspas is attributed to their provision of aesthetic treatments under the supervision of licensed medical practitioners. Medspas leverage innovative, cutting-edge technology and products to offer clinical treatments aligned with modern medicine. Presently, the millennial population represents the largest target demographic for medical-grade skincare brands.

According to the American Med Spa Association, the revenue of the U.S. medspa industry has experienced double-digit growth since 2010, with a significant portion of medspa patients falling within the 35-54 age bracket. Additionally, the emergence of prominent medical spa chains like Orange Twist, Beverly Hills Rejuvenation Centre, and Kalologie 360 is expected to further propel market growth in the country, as reported by the Association in 2018.

Regional Insights

In 2023, Asia Pacific emerged as the dominant market, capturing a revenue share of more than 41%, and is poised to experience robust growth throughout the projection period. Asia Pacific presents a significant export market potential for U.S.-based products due to its vast consumer base of over 3 billion individuals seeking anti-acne cosmetic products. According to a study by JAMA Dermatology, in Westernized societies like the U.S., acne is a prevalent skin condition affecting 79 to 95% of the adolescent population.

Economies such as Australia, Japan, and South Korea stand out as some of the largest consumers of well-established U.S.-based products. For instance, in 2021, Galderma Korea introduced a new acne treatment called Aklief designed to address torso and facial acne following successful clinical trials. Aklief demonstrated positive outcomes by effectively reducing inflammatory lesions within a reasonable timeframe.

Read More: https://www.heathcareinsights.com/dermatology-devices-market/

Anti-acne Cosmetics Market Key Companies

Anti-acne Cosmetics Market Segmentations:

By Product Type

By Gender

By End-use

By Region

Buy this Premium Research Report@ https://www.visionresearchreports.com/report/checkout/39047

You can place an order or ask any questions, please feel free to contact sales@visionresearchreports.com| +1 650-460-3308

Web: https://www.visionresearchreports.com/

Blog: https://www.novaoneadvisor.com/

Exit mobile version